Description
Recombinant monoclonal antibody to CD86. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma PO3. This chimeric mouse antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques.
Target
CD86
Target Alias Names
PO.3, PO3.1, B7-2, Activation B7-2 antigen, B-lymphocyte activation antigen B7-2, B-lymphocyte antigen B7-2, B7.2, CD28 antigen ligand 2, CD28LG2, CD86, early T cell costimulatory molecule-1, early T-cell costimulatory molecule 1, ETC-1, LAB72, MGC34413, T-lymphocyte activation antigen CD86
Isotype/Mimetic
IgG1-D265A
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression